CLMB vs KIDS
CLMB: A global value-added IT distributor specializing in the channel-led delivery of emerging and disruptive software, cloud, and infrastructure solutions. KIDS: The only global medical device company dedicated exclusively to the pediatric orthopedic market, offering specialized implants, bracing, and O&P clinical services for children.
Side-by-side fundamentals
| Metric | CLMB | KIDS | Edge |
|---|---|---|---|
| Price as of 2026-10-30 close | $40.64 | $30.87 | |
| Market cap | $758M | $806M | |
| P/E as of 2026-10-30 | 8.54 | n/a | |
| PEG as of 2026-10-30, 3-year EPS CAGR to FY2025 | 0.47 | n/a | |
| Net margin FY2025, SEC XBRL | +3.3% | -16.8% | CLMB higher |
| Gross margin FY2025, SEC XBRL | +16.1% | +73.1% | KIDS higher |
| Operating margin FY2025, SEC XBRL | +4.5% | -16.6% | CLMB higher |
| ROE FY2025, SEC XBRL | +18.3% | -11.4% | CLMB higher |
| ROA FY2025, SEC XBRL | +4.6% | -7.8% | CLMB higher |
| Debt / equity filed borrowings, leases excl., balance sheet 2026-09-30 | 0.00 | 0.30 | CLMB lower |
| Revenue growth (YoY) FY2025, SEC XBRL | +40.1% | +15.4% | CLMB higher |
| Revenue CAGR (3y) SEC XBRL | +4.8% | +24.6% | KIDS higher |
| Dividend streak (yrs) SEC XBRL | 11 | 0 | CLMB higher |
| Beta as of 2026-09-03 | 0.92 | 0.97 | |
| 1-year return as of 2026-10-30 close | +32.4% | +87.4% | KIDS higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-30.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.